Clinical Trial

Nordic ORgan Preservation Pilot Approach Nonrandomised Single-Arm Trial for Non-Operative Management of Rectal Cancer

Study acronym: NORPPA-1
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this one-arm clinical trial is to implement and study the oncological outcomes of nonoperative management of rectal cancer having complete clinical response to neoadjuvant therapy. The main questions to answer are * if the oncological results of nonoperative management after Nordic practice in chemoradiotherapy indications differ from experiences elsewhere * what is the organ preservation rate * what is the local regrowth rate
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-03-18; most recent amendment 2025-08-25.
Status change: Not Yet Recruiting → Recruiting 2024-04-30
Trial Details
NCT Number NCT06328361
Lead Sponsor Tampere University Hospital
Collaborators: Tampere University, Helsinki University Central Hospital, Turku University Hospital, Kuopio University Hospital, Oulu University Hospital, Jyväskylä Central Hospital, Seinajoki Central Hospital, Satakunta Central Hospital, North Karelia Central Hospital, Tartu University Hospital, East Tallinn Central Hospital, West Tallinn Central Hospital, North Estonia Medical Centre, Vaasa Central Hospital, Vaasa, Finland
Conditions Rectal Cancer, Rectal Adenocarcinoma
Enrollment 200 participants
Start Date 2024-05-16
Primary Completion 2028-12-31 (estimated)
Study Completion 2032-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-02